Oklahoma City, Oklahoma — Oklahoma City, Oklahoma

Oklahoma City, Oklahoma is a clinical research site located in Oklahoma City, Oklahoma, United States 73102-1018.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Oklahoma City, Oklahoma has participated in 4 clinical trials.

Therapeutic areas: Schizophrenia, Seizures, Panic Disorder.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oklahoma City, Oklahoma?

Oklahoma City, Oklahoma has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oklahoma City, Oklahoma conducted?

Oklahoma City, Oklahoma has 4 clinical trials on record. Their work covers Schizophrenia, Seizures, Panic Disorder.

Is Oklahoma City, Oklahoma accredited by Crixeo Health?

Oklahoma City, Oklahoma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oklahoma City, Oklahoma?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.